Trince
Gent, BE · 4 known investors
Find your way into Trince
Trince is a Ghent University spin-off developing photoporation technology for physical transfection of cells as an alternative to viral vectors and electroporation. Its technology, including the Lumipore platform, targets R&D, manufacturing, and GMP-compliant clinical applications such as cell and gene therapy.
Founders & leadership
P
Philip
K
Kevin
Investors · 4
Also in the syndicate · 2
Novalis Biotech AccelerationleadQbic II
Funding
SEC filings, press & company announcements- Undisclosed amountSeedDec 2025 · 2 sourcesSource ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Trince do?
- Trince is a Ghent University spin-off developing photoporation technology for physical transfection of cells as an alternative to viral vectors and electroporation. Its technology, including the Lumipore platform, targets R&D, manufacturing, and GMP-compliant clinical applications such as cell and gene therapy.
- Who are Trince's investors?
- Trince's investors include Novalis Biotech, Qbic Fund.
- Where is Trince headquartered?
- Trince is headquartered in Gent, BE.